![Mohammad Hirmand](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mohammad Hirmand
Directeur/Membre du Conseil chez
WHITEHAWK THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Le Dr Mohammad Hirmand, MD, est médecin en chef et vice-président exécutif de Turning Point Therapeutics, Inc. Auparavant, le Dr Hirmand a occupé les postes de vice-président du développement clinique chez Medivation LLC (Californie), de directeur associé de la recherche clinique chez Amgen, Inc., de directeur principal du développement clinique chez ARCA biopharma, Inc. et de directeur du développement du marché et de l'évaluation des produits chez Innoviva, Inc, directeur principal du développement clinique chez Nuvelo, Inc, directeur médical chez Peloton Therapeutics, Inc, directeur du développement oncologique chez SuperGen, Inc, directeur chez Theravance Biopharma US, Inc, et directeur des données cliniques chez Tularik, Inc. Il a obtenu son diplôme de premier cycle à l'Université Cornell et un doctorat à la Harvard Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Mohammad Hirmand
| Sociétés | Poste | Début |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 27/03/2023 |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Fondateur | 01/08/2022 |
Atavistik Bio, Inc.
 Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | Directeur/Membre du Conseil | - |
Anciens postes connus de Mohammad Hirmand
| Sociétés | Poste | Fin |
|---|---|---|
| TURG POIN | Directeur Technique/Scientifique/R&D | 01/08/2022 |
| PELOTON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 31/12/2019 |
| MEDIVATION INC | Directeur des opérations | 01/10/2015 |
Theravance Biopharma US, Inc.
 Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Corporate Officer/Principal | - |
| ARCA BIOPHARMA | Corporate Officer/Principal | - |
Formation de Mohammad Hirmand
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
39
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs, diagnostics and other therapeutic products | Health Technology |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
ARCA biopharma, Inc.
 ARCA biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Commercial Services |
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Develops precision allosteric therapeutics | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Health Technology |
